Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière

NCT ID: NCT06026696

Last Updated: 2023-09-07

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Total Enrollment: 5000 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2023-09-30
• Study Completion Date: 2038-09-30

Brief Summary

Neurovascular diseases can cause ischaemic or haemorrhagic strokes. While the most common, such as atherosclerosis are widely studied, others are less well known, such as arterial dissections or cerebral angiopathies. What's more, most studies are limited to a few years' follow-up and the longer-term evolution of patients is less well assessed. Patient follow-up data available in routine practice and specific enrollment through the headache emergencies of the Lariboisière neurovascular intensive care unit (USINV) could provide a particularly rich resource.

Conditions

Ischemic Stroke; Hemorrhagic Stroke

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: CROSS_SECTIONAL

Study Groups

Patients treated for acute cerebrovascular pathology cerebrovascular disease

follow-up

Intervention Type: OTHER

Long term follow-up

Interventions

follow-up

Long term follow-up

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Adult patients ≥18 years

2. Patients admitted to the Neurovascular Intensive Care Unit with acute cerebrovascular disease OR Patients managed for acute cerebrovascular pathology with or without stroke by the Lariboisière neurology team.

3. No opposition from the patient to the research and for patients under guardianship or guardianship or lack of capacity to object (severe impairment of cognitive functions, dementia, etc.), no opposition from the legal representative.

Exclusion Criteria

1. Patient refusing to take part in the study or refusal by the legal representative in the case of patients under guardianship or curatorship

2. Patient suffering from a rare neurovascular disease and being followed at the "Centre de référence des maladies vasculaires rares du cerveau et de l'oeil" (CERVCO)

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 100 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Central Contacts

Peggy Reiner, Dr

Role: CONTACT

peggy.reiner@aphp.fr

+33149956525

Jérôme Lambert, Dr

Role: CONTACT

jerome.lambert@u-paris.fr

+33142499742

Other Identifiers

APHP221076

Identifier Type: -

Identifier Source: org_study_id